Cite

HARVARD Citation

    Wei, L. et al. (2022). Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial. Hepatology. 75 (1), pp. 182-195. [Online]. 
  
Back to record